Filter
4799
Filtered Results: 4799
Text search:
drug
policy
Featured
Recommendations
391
New Publications
1300
Language
Document type
No document type
2946
Studies & Reports
735
Guidelines
552
Manuals
201
Strategic & Response Plan
169
Fact sheets
61
Training Material
57
Situation Updates
45
Infographics
11
Resource Platforms
9
Brochures
6
Online Courses
5
App
2
Countries / Regions
India
245
Kenya
158
Global
156
Uganda
119
South Africa
115
Western and Central Europe
111
Nigeria
108
Ethiopia
106
Nepal
95
Liberia
82
Sierra Leone
81
Malawi
81
Tanzania
81
Zambia
78
Myanmar / Burma
76
Ghana
73
Latin America and the Carribbean
67
Bangladesh
67
Africa
64
Eastern Europe
59
Namibia
58
Rwanda
55
Ukraine
54
Zimbabwe
46
Asia
43
Philippines
38
Lesotho
36
South–East Asia Region
36
Cambodia
35
Russia
33
Indonesia
32
Botswana
28
Eswatini/ Swaziland
23
Mozambique
22
Congo, Democratic Republic of
22
Syria
20
Senegal
19
Colombia
18
Burkina Faso
18
East and Southern Africa
15
Brazil
15
Haiti
13
Venezuela
13
Germany
13
West and Central Africa
13
Cameroon
12
Middle East and North Africa
12
Pakistan
12
Eastern Europe and Central Asia
11
South Sudan
11
Tajikistan
10
Thailand
10
Albania
10
Guinea
10
Georgia
10
Afghanistan
9
Peru
9
Sudan
9
Paraguay
8
Vietnam
8
China
7
USA
7
Moldova
7
North Macedonia
6
Benin
6
Laos
6
Armenia
6
Sri Lanka
6
Yemen
6
Mexico
5
El Salvador
5
Western Pacific Region
5
North America
5
Timor Leste/ East Timor
4
Iran
4
Jordan
4
United Kingdom
4
Argentina
4
Central African Republic
4
Libya
4
Bhutan
4
Iraq
4
Somalia
4
Turkey
3
Fiji
3
Estonia
3
Kyrgyzstan
3
Jamaica
3
Bolivia
3
Lebanon
3
Palestine
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Romania
2
Poland
2
Mali
2
North Korea
1
Switzerland
1
Gambia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Egypt
1
Greece
1
Honduras
1
Angola
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1936
Clinical Guidelines
359
Public Health
227
Women & Child Health
172
Key Resources
138
Capacity Building
53
Pharmacy & Technologies
53
Toolboxes
HIV
612
TB
525
Mental Health
455
AMR
248
COVID-19
177
Pharmacy
141
NTDs
121
NCDs
88
Caregiver
83
Malaria
81
Rapid Response
68
Planetary Health
66
Ebola & Marburg
62
Refugee
58
Global Health Education
57
Disability
53
Conflict
50
Health Financing Toolbox
43
Polio
24
Natural Hazards
17
Specific Hazards
14
Cholera
14
Social Ethics
10
Zika
8
The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendium are all either part of existing indicators used i...
This updated implementation guidance is intended for all those who set policy for, or offer care to, pregnant women, families and infants: governments; national managers of maternal and child health programmes in general, and of breastfeeding- and BFHI-related programmes in particular; and health-f...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
From 2000 to 2010, Rwanda implemented comprehensive health sector reforms to strengthen the public health system, with the aim of reducing maternal and newborn deaths in line with Millennium Development Goal 5, among many other improvements in national health. Based on a systematic review of the lit...
Recommendations for a Public Health approach and considerations for policy-makers and managers
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
This resource aims to provide relevant and practical guidance to DRR practitioners (policy and programme colleagues), on how to ensure inclusion - particularly of vulnerable groups - in Community-Based DRR (CBDRR) initiatives in Myanmar. It comprises an overall Framework for inclusive CBDRR and a nu...
Submission by the WHO Collaborating Centre on training and policy on opioid availability and WHO collaborating Centre for community participation in palliative care and long term care To the Indian Nursing Council for consideration to be included in the Undergraduate Nursing education curriculum
These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents
UN GUIDE POUR L’APPROVISIONNEMENTEN MÉDICAMENTS/ A guide for drug supply
Bochure in English and French
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2...
